Online first
Study Protocol
Published online: 2025-03-20
Preventing chronic heart failure and improving survival after transcatheter aortic valve implantation in patients with the need for permanent pacemaker implantation: Rationale and design of the physiologic cardiac pacing to prevent left ventricular dysfunction post transcatheter aortic valve implantation (PACE-4-TAVI) trial
1
, 1, 1, 2, 2, 34, 5, 6, 78, 9, 10, 11, 1
, 1, 1, 2, 2, 34, 5, 6, 78, 9, 10, 11, 1
DOI: 10.5603/cj.100726
Pubmed: 40109249
Abstract
Not available
Keywords: atrioventricular blockbiventricular pacingconduction system pacingheart failurepacing-induced cardiomyopathyright ventricular pacingtranscatheter aortic valve implantation
References
- Peters AS, Duggan JP, Trachiotis GD, et al. Epidemiology of Valvular Heart Disease. Surg Clin North Am. 2022; 102(3): 517–528.
- Correction to: Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017. Circulation. 2020; 141(21): e836.
- Leon MB, Smith CR, Mack M, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17): 1597–1607.
- Smith CR, Leon MB, Mack MJ, et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23): 2187–2198.
- Leon M, Smith C, Mack M, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. New England Journal of Medicine. 2016; 374(17): 1609–1620.
- Pibarot P, Salaun E, Dahou A, et al. PARTNER 3 Investigators, PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18): 1695–1705.
- Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS Scientific Document Group, ESC/EACTS Scientific Document Group, ESC/EACTS Scientific Document Group, ESC/EACTS Scientific Document Group, ESC/EACTS Scientific Document Group, ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021; 60(4): 727–800.
- Auffret V, Puri R, Urena M, et al. Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives. Circulation. 2017; 136(11): 1049–1069.
- Sammour Y, Krishnaswamy A, Kumar A, et al. Incidence, Predictors, and Implications of Permanent Pacemaker Requirement After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2021; 14(2): 115–134.
- Hudziak D, Targoński R, Wańha W, et al. Comparison of transcarotid versus transapical transcatheter aortic valve implantation outcomes in patients with severe aortic stenosis and contraindications for transfemoral access. Cardiol J. 2023; 30(2): 188–195.
- Nazif TM, Dizon JM, Hahn RT, et al. PARTNER Publications Office. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014; 35(24): 1599–1607.
- Dykun I, Mahabadi AA, Jehn S, et al. The degree of permanent pacemaker dependence and clinical outcomes following transcatheter aortic valve implantation: implications for procedural technique. Eur Heart J Open. 2023; 3(6): oead127.
- Glikson M, Nielsen JC, Kronborg MB, et al. ESC Scientific Document Group, ESC Scientific Document Group, ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022; 24(1): 71–164.
- Stiles MK, Fauchier L, Morillo CA, et al. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2020; 17(1): e220–e228.
- Wilkoff BL, Kudenchuk PJ, Buxton AE, et al. DAVID II Investigators, Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002; 288(24): 3115–3123.
- Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. MOde Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003; 107(23): 2932–2937.
- Curtis AB, Worley SJ, Adamson PB, et al. Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013; 368(17): 1585–1593.
- Vijayaraman P, Naperkowski A, Subzposh FA, et al. Permanent His-bundle pacing: Long-term lead performance and clinical outcomes. Heart Rhythm. 2018; 15(5): 696–702.
- Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2016; 9(21): 2189–2199.
- D'Ancona G, Pasic M, Unbehaun A, et al. Permanent pacemaker implantation after transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2011; 13(4): 373–376.
- Gonska B, Keßler M, Wöhrle J, et al. Influence of permanent pacemaker implantation after transcatheter aortic valve implantation with new-generation devices. Neth Heart J. 2018; 26(12): 620–627.
- Chamandi C, Barbanti M, Munoz-Garcia A, et al. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2018; 11(3): 301–310.
- Jarosinski G, Jasinski M, Deja M, et al. Survival after Transcatheter Aortic Valve Replacemnt With or Without Pacemaker Iimplantation. J Am Coll Cardiol. 2021; 77(18): 92–97.
- Abu Rmilah AA, Al-Zu'bi H, Haq IU, et al. Predicting permanent pacemaker implantation following transcatheter aortic valve replacement: A contemporary meta-analysis of 981,168 patients. Heart Rhythm O2. 2022; 3(4): 385–392.
- Costa G, Zappulla P, Barbanti M, et al. Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes. EuroIntervention. 2019; 15(10): 875–883.
- Tanaka H, Hara H, Adelstein EC, et al. Comparative mechanical activation mapping of RV pacing to LBBB by 2D and 3D speckle tracking and association with response to resynchronization therapy. JACC Cardiovasc Imaging. 2010; 3(5): 461–471.
- Somma V, Ha FJ, Palmer S, et al. Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management. Heart Rhythm. 2023; 20(2): 282–290.
- Kiehl EL, Makki T, Kumar R, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm. 2016; 13(12): 2272–2278.
- Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014; 11(9): 1619–1625.
- Szotek M, Drużbicki Ł, Sabatowski K, et al. Transcatheter Aortic Valve Implantation and Cardiac Conduction Abnormalities: Prevalence, Risk Factors and Management. J Clin Med. 2023; 12(18).
